By Business/Source
Currency:JPY
2026/Q1
Stock NameRevenueRatio
Research, development, manufacturing, marketing and out-licensing of pharmaceutical products1.11T100.00%
By Country/Region
Currency:JPY
2025/FY
Stock NameRevenueRatio
United States (US)2.38T51.94%
Europe and Canada1.06T23.03%
Japan418.46B9.13%
Latin America235.85B5.15%
China191.74B4.19%
Other128.85B2.81%
Asia (excluding Japan & China)99.39B2.17%
Russia/Commonwealth of Independent States (CIS)72.36B1.58%
View all